- Home
- ELA vs SCPH Comparison
ELA vs SCPH Comparison
Compare ELA & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELA
- SCPH
- Stock Information
- Founded
- ELA 1965
- SCPH 2013
- Country
- ELA United States
- SCPH United States
- Employees
- ELA N/A
- SCPH N/A
- Industry
- ELA Consumer Specialties
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- ELA Consumer Discretionary
- SCPH Health Care
- Exchange
- ELA Nasdaq
- SCPH Nasdaq
- Market Cap
- ELA 175.2M
- SCPH 173.6M
- IPO Year
- ELA N/A
- SCPH 2017
- Fundamental
- Price
- ELA $6.60
- SCPH $3.25
- Analyst Decision
- ELA Strong Buy
- SCPH Strong Buy
- Analyst Count
- ELA 1
- SCPH 2
- Target Price
- ELA $7.00
- SCPH $15.00
- AVG Volume (30 Days)
- ELA 16.9K
- SCPH 267.8K
- Earning Date
- ELA 03-19-2025
- SCPH 03-12-2025
- Dividend Yield
- ELA N/A
- SCPH N/A
- EPS Growth
- ELA N/A
- SCPH N/A
- EPS
- ELA 0.25
- SCPH N/A
- Revenue
- ELA $165,946,534.00
- SCPH $30,278,000.00
- Revenue This Year
- ELA $1.61
- SCPH $172.27
- Revenue Next Year
- ELA $6.30
- SCPH $131.75
- P/E Ratio
- ELA $26.88
- SCPH N/A
- Revenue Growth
- ELA N/A
- SCPH 303.87
- 52 Week Low
- ELA $4.20
- SCPH $3.08
- 52 Week High
- ELA $7.88
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- ELA 40.78
- SCPH 43.27
- Support Level
- ELA $6.45
- SCPH $3.09
- Resistance Level
- ELA $6.90
- SCPH $3.87
- Average True Range (ATR)
- ELA 0.34
- SCPH 0.20
- MACD
- ELA -0.02
- SCPH 0.00
- Stochastic Oscillator
- ELA 55.45
- SCPH 20.65
About ELA Envela Corporation
Envela Corp and its subsidiaries engage in diverse business activities within the recommerce sector. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.